Rockville firm Vigene Biosciences sold for $293 million
Plus: County to host 24th Juneteenth celebration; Hogan signs bill repealing Civil War-era state song Bethesda Beat Staff | May 19, 2021 Rockville bioscience firm sold for $293M Charles River Laboratories, a Massachusetts drug research company, said Monday it has signed a deal to buy Vigene Biosciences, a Rockville gene therapy contract development and manufacturing organization, for $292.5 million. In addition to the initial purchase price, Vigene is eligible for up to $57.5 million based on how well it meets certain goals. [Boston Globe] County to host 24th Juneteenth celebration Montg...